Fatigue after treatment for malignant and benign bone and soft tissue tumors

被引:77
作者
Servaes, P
Verhagen, S
Schreuder, B
Veth, RPH
Bleijenberg, G
机构
[1] Univ Nijmegen, Ctr Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Ctr Med, Netherlands Fatigue Res Grp, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Ctr Med, Netherlands Fatigue Res Grp, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands
[4] Univ Nijmegen, Ctr Med, Netherlands Fatigue Res Grp, Dept Orthoped, NL-6500 HB Nijmegen, Netherlands
关键词
bone and soft tissue tumors; fatigue; post-treatment; longitudinal;
D O I
10.1016/j.jpainsymman.2003.03.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Fatigue has been mentioned as an important complaint in several groups of disease-free patients after curative treatment for cancer. However, it has never been investigated in a sample of patients who have been treated for a bone or soft tissue tumor in the past. In the current study, these patients participated. Measurement included posted questionnaires at baseline and at follow-up (two years later). Baseline results indicated that fatigue is a severe problem for 28% of the investigated patients. Percentages were equal for Patients who were treated for malignant or benign tumors. Fatigue complaints seem to be most severe for patients who finished treatment relatively recently, and for patients who had to undergo more than one operation. In addition, fatigue was associated with several psychological and physical variables. At follow-up, the majority of all patients who were severely fatigued at baseline continued to be severely fatigued. Severe fatigue at follow-up was predicted by oncological complications after initial treatment, less optimism, and more somatization. It can be concluded that fatigue is an important problem for more than a quarter of a sample of patients who have been treated for a malignant or benign bone or soft tissue tumor in the past. (C) 2003 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1113 / 1122
页数:10
相关论文
共 36 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Off-treatment fatigue in breast cancer survivors: A controlled comparison [J].
Andrykowski, MA ;
Curran, SL ;
Lightner, R .
JOURNAL OF BEHAVIORAL MEDICINE, 1998, 21 (01) :1-18
[3]  
[Anonymous], GEDRAG GEZONDHEID
[4]  
Arindell WA, 1986, SCL 90 HANDLEIDING B
[5]   Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life [J].
Bower, JE ;
Ganz, PA ;
Desmond, KA ;
Rowland, JH ;
Meyerowitz, BE ;
Belin, TR .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :743-753
[6]   Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer [J].
Broeckel, JA ;
Jacobsen, PB ;
Horton, J ;
Balducci, L ;
Lyman, GH .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1689-1696
[7]  
BROOK RH, 1979, MED CARE, V17, P127
[8]  
Christ GH, 1995, J PSYCHOSOC ONCOL, V13, P1
[9]  
Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353
[10]  
Deale A, 1997, AM J PSYCHIAT, V154, P408